Technical Analysis for AEMD - Aethlon Medical, Inc.

Grade Last Price % Change Price Change
grade F 3.13 17.67% 0.47
AEMD closed down 9.44 percent on Tuesday, November 19, 2019, on 40 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AEMD trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 17.67%
New 52 Week Low Weakness 17.67%
Wide Bands Range Expansion 17.67%
Below Lower BB Weakness 17.67%
Down 3 Days in a Row Weakness 17.67%
Down 4 Days in a Row Weakness 17.67%
Down 5 Days in a Row Weakness 17.67%
Gapped Down Weakness 17.67%
Lower Bollinger Band Touch Weakness 17.67%
Oversold Stochastic Weakness 17.67%

Older signals for AEMD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aethlon Medical, Inc., a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The company's Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. It is also developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. The company was founded in 1991 and is based in San Diego, California.
Medicine Health Cancer Biology Infectious Diseases Treatment Of Cancer Neurological Disorders Hepatitis Infectious Causes Of Cancer Healthcare Associated Infections Antiviral Drug Virus Sepsis Exosome Vesicles
Is AEMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.1
52 Week Low 2.63
Average Volume 28,085
200-Day Moving Average 7.615
50-Day Moving Average 3.8979
20-Day Moving Average 3.7065
10-Day Moving Average 3.282
Average True Range 0.5121
ADX 21.2
+DI 16.7959
-DI 27.2034
Chandelier Exit (Long, 3 ATRs ) 3.4837
Chandelier Exit (Short, 3 ATRs ) 4.1663
Upper Bollinger Band 4.7529
Lower Bollinger Band 2.6601
Percent B (%b) 0.0
BandWidth 56.46297
MACD Line -0.3001
MACD Signal Line -0.1929
MACD Histogram -0.1072
Fundamentals Value
Market Cap 23.67 Million
Num Shares 8.9 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -3.06
Price-to-Sales 22.89
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.06
Resistance 3 (R3) 3.10 3.00 3.00
Resistance 2 (R2) 3.00 2.90 2.98 2.97
Resistance 1 (R1) 2.83 2.83 2.78 2.79 2.95
Pivot Point 2.73 2.73 2.70 2.71 2.73
Support 1 (S1) 2.56 2.63 2.51 2.53 2.37
Support 2 (S2) 2.46 2.56 2.44 2.35
Support 3 (S3) 2.29 2.46 2.32
Support 4 (S4) 2.26